Radiotherapy Market Share Report | Trends, Size & Forecasts 2028
[研究报告] 放射治疗市场规模预计将从 2020 年的 64.7478 亿美元增至 2028 年的 101.708 亿美元;预计 2021 年至 2028 年的复合年增长率为 5.9%。
市场洞察和分析师观点:
放射治疗,也称为放射疗法,是一种利用高能辐射瞄准并摧毁恶性(癌性)细胞的医疗方法。它是癌症治疗的重要组成部分,用于治愈癌症、控制其生长或缓解症状。放射治疗通常涉及电离辐射,例如 X 射线或伽马射线,以攻击癌细胞并阻碍其生长和繁殖的能力。它可以通过外部使用将辐射导向癌变区域的机器(外束放射治疗)进行治疗,也可以通过在受影响细胞附近插入体内放射源(近距离放射治疗)进行治疗。放射治疗的目标是向肿瘤提供精确瞄准的辐射剂量,最大限度地减少对周围健康组织的损害,同时最大限度地发挥其对癌细胞的作用。放射治疗与其他癌症治疗(如手术和化疗)结合使用。它在实施时要仔细考虑癌症类型、分期和患者的整体健康状况。因此,放射治疗在癌症的综合管理中发挥着至关重要的作用,它提供了一种有效的局部治疗肿瘤的方法,同时努力保留健康组织并改善患者的治疗效果。
增长动力和机遇:
放射治疗市场增长的主要驱动力是癌症患者数量的增加、政府和非政府对癌症治疗研发的巨额投资以及降低医疗成本的日益增长的需求。世界正在见证癌症患者数量的显着增加。根据世界卫生组织 (WHO) 的数据,癌症是全球第二大死亡原因,2022 年报告的死亡人数约为 1000 万人。在所有癌症类型中,乳腺癌被认为是全球女性中最常见的癌症,其发病率在全球范围内呈上升趋势。生活方式的改变、荷尔蒙失衡、遗传倾向和环境因素等因素导致乳腺癌患病率上升。根据美国癌症协会的数据,大约 5-10% 的所有恶性肿瘤是由从父母那里遗传的基因引起的。已经发现了几种癌症易感基因。例如,遗传癌症易感基因 BRCA1 和 BRCA2 的突变会增加患上某些恶性肿瘤的风险,例如乳腺癌、卵巢癌和前列腺癌。
此外,乳腺癌是美国最常见的癌症类型之一。Breastcancer.org 于 2022 年 1 月发布的一份报告指出,美国每 8 名女性中就有 1 名(或约 13%)将在其一生中患上浸润性乳腺癌。根据同一来源,预计 2022 年美国女性中将发现 287,850 例新的浸润性乳腺癌病例以及 51,400 例新的非浸润性(原位)乳腺癌病例。同年,该国预计将记录约 2,710 例男性浸润性乳腺癌病例。大约每 833 名男性中就有 1 人可能在其一生中患上乳腺癌。随着乳腺癌病例的增加,对有效和有针对性的治疗以改善患者预后的需求也日益增加。这导致乳腺癌治疗研究和开发活动激增。乳腺癌发病率的上升凸显了放射治疗在这种常见恶性肿瘤的综合治疗中的重要作用。随着乳腺癌确诊人数不断增加,放射治疗已成为多学科癌症治疗方法中的关键手段。放射治疗在乳腺癌治疗中发挥着关键作用,可用于多种目的,例如术后治疗以清除残留癌细胞、新辅助治疗以在手术前缩小肿瘤以及辅助治疗以降低癌症复发风险。此外,放射治疗还可用于缓解晚期或转移性乳腺癌的症状并改善治疗效果。
定制研究以满足您的需求
我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。
放射治疗市场:
Radiotherapy Market: Strategic Insights
Radiotherapy Market
-
CAGR (2020 - 2028)
5.9%
-
Market Size 2020
US$ 6.47 Billion
-
Market Size 2028
US$ 10.17 Billion
Market Dynamics
GROWTH DRIVERS
- 癌症患者数量不断增加
- 政府和非政府对癌症治疗研发的巨额投资
FUTURE TRENDS
- 政府为发展中国家改善医疗保健而采取的举措
OPPORTUNITIES
- 癌症放射治疗新技术
Key Players
- Siemens Healthineers AG
- Accuray Incorporated
- Sumitomo Heavy Industries Ltd
- Elekta AB
- Hitachi Ltd
- Koninklijke Philips N V
- Brainlab AG
- PROTOM INTERNATIONAL
- Varian Medical Systems Inc
Regional Overview
- 北美(美国、加拿大、墨西哥)
- 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
- 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
- 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
- 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
Market Segmentation
类型(外照射放射治疗、内照射放射治疗和全身放射治疗)
应用(皮肤和唇癌、乳腺癌、前列腺癌、宫颈癌、肺癌等)
最终用户(医院、研究机构、门诊和放射治疗中心)
地理(北美洲、欧洲、亚太地区、中东和非洲、南美洲和中美洲)
Radiotherapy Market: Strategic Insights
-
CAGR (2020 - 2028)5.9% -
Market Size 2020
US$ 6.47 Billion -
Market Size 2028
US$ 10.17 Billion
Market Dynamics
- 癌症患者数量不断增加
- 政府和非政府对癌症治疗研发的巨额投资
- 政府为发展中国家改善医疗保健而采取的举措
- 癌症放射治疗新技术
Key Players
- Siemens Healthineers AG
- Accuray Incorporated
- Sumitomo Heavy Industries Ltd
- Elekta AB
- Hitachi Ltd
- Koninklijke Philips N V
- Brainlab AG
- PROTOM INTERNATIONAL
- Varian Medical Systems Inc
Regional Overview
- 北美(美国、加拿大、墨西哥)
- 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
- 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
- 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
- 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
Market Segmentation
复合年增长率(2020 - 2028 年)5.9%- 2020 年市场规模
64.7 亿美元 - 2028 年市场规模
101.7 亿美元
市场动态
- 癌症患者数量不断增加
- 政府和非政府对癌症治疗研发的巨额投资
- 政府为发展中国家改善医疗保健而采取的举措
- 癌症放射治疗新技术
关键人物;主力;重要一员
- 西门子医疗股份公司
- Accuray 公司
- 住友重工业株式会社
- 医科达公司
- 日立制作所有限公司
- 荷兰皇家飞利浦公司
- Brainlab 公司
- 普罗托姆国际
- 瓦里安医疗系统公司
区域概况
- 北美
- 欧洲
- 亚太
- 南美洲和中美洲
- 中东和非洲
市场细分
- 外照射放射治疗
- 内部放射治疗
- 全身放射治疗
- 皮肤和唇癌
- 乳腺癌
- 前列腺癌
- 宫颈癌
- 肺癌及其他
- 医院
- 研究机构、门诊和放射治疗中心
- 北美
- 欧洲
- 亚太地区
- 中东和非洲
- 南美洲和中美洲
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
另一方面,缺乏熟练的放射治疗人员是制约放射治疗服务发展和普及的一大瓶颈,尤其是在医疗人员短缺的地区。熟练的放射肿瘤学家、医学物理学家、放射治疗师和剂量师对于有效安全地实施放射治疗至关重要。然而,这些高度专业化的专业人员的全球短缺限制了医疗机构提供关键放射治疗的能力,导致患者等待时间增加、治疗机会不理想,并给医疗保健系统带来压力。
因此,技术人员的短缺阻碍了放射治疗市场的扩张和普及,降低了在各种医疗环境中更广泛地采用和利用放射治疗服务的可能性。熟练专业人员的有限性阻碍了为癌症患者提供及时和最佳放射治疗的能力。它影响了医疗机构充分利用先进放射治疗技术和技巧的能力。此外,多方利益相关者合作、国际伙伴关系和建立专业发展支持框架对于解决熟练人员短缺、促进放射治疗服务的扩张和有效性以及确保患者能够获得所需的关键治疗至关重要。
报告细分和范围:
“全球放射治疗市场”根据类型、应用、最终用户和地区进行细分。放射治疗市场大致分为全身、外束和内部放射治疗。放射治疗市场根据应用进行分类,例如皮肤和唇癌、乳腺癌、前列腺癌、宫颈癌、肺癌等。放射治疗市场的最终用户部分大致分为医院、门诊和放射治疗中心等。基于地理的放射治疗市场分为北美(美国、加拿大和墨西哥)、欧洲(德国、法国、意大利、英国和欧洲其他地区)、亚太地区(澳大利亚、中国、日本、印度、韩国和亚太地区其他地区)、中东和非洲(南非、沙特阿拉伯、阿联酋和中东和非洲其他地区)以及南美洲和中美洲(巴西、阿根廷和南美洲和中美洲其他地区)
节段分析:
根据类型,放射治疗市场细分为外部束、内部和全身放射治疗。2022 年,放射治疗市场收入主要归因于外部束放射治疗,该治疗占比最大。由于发达国家和发展中国家癌症发病率和患病率上升、技术发展和医疗支出增加,全球放射治疗市场预计将在预测期内增长。为了改善患者的治疗效果,癌症中心正在扩大外部束放射治疗的可用性,包括立体定向放射外科、调强放射治疗 (IMRT) 和 3-D 适形放射治疗。由于这些治疗选择,医疗保健公司可以扩大其在癌症放射治疗方面的研发工作。
根据癌症细分市场,放射治疗市场细分为皮肤癌和唇癌、乳腺癌、前列腺癌、宫颈癌、肺癌等。皮肤癌包括鳞状细胞癌、黑色素瘤和基底细胞癌,大多因暴露于紫外线 (UV) 而发生在皮肤细胞中。唇癌的三大主要病因是吸烟、免疫系统受损和紫外线照射。预计在整个预测期内,皮肤癌和唇癌细分市场将显著增长。皮肤癌和唇癌发病率不断上升、大量研发渠道、放射技术的改进、对放射治疗等非侵入性癌症治疗的需求不断增长以及全球放射治疗服务的普及率不断提高,这些都是推动该细分市场增长的一些因素。例如,根据美国癌症协会 2023 年 1 月的数据,到 2023 年底,美国将发现 97,610 例黑色素瘤病例,其中男性 58,120 例,女性 39,490 例。因此,由于皮肤和唇癌发病率的增加,用于治疗目的的放射设备的需求将相当大,这将推动市场扩张。
根据最终用户,放射治疗市场分为医院、门诊和放射治疗中心以及其他。在整个预测期内,医院部门预计将占据相当大的全球市场份额。这是由于癌症患者数量的增加以及医院使用不同放射治疗的增加。
区域分析:
根据地域,全球放射治疗市场分为五个主要区域:北美、欧洲、亚太地区、南美和中美、中东和非洲。
预计北美在整个预测期内将见证放射治疗市场的显著扩张。癌症发病率和患病率的上升、该领域的主要公司以及创新产品的推出都促进了市场的扩张。根据 2023 年 1 月更新的数据,美国癌症协会认为美国女性中最常见的癌症是乳腺癌。它占美国每年新诊断的女性癌症总数的三分之一,即 30%。同一消息来源预测,到 2023 年底,女性将新诊断出 297,790 例浸润性乳腺癌和 55,720 例导管原位癌 (DCIS)。预计癌症负担将推动该国对放射治疗的需求。因此,该国的高癌症发病率和患病率需要开发复杂的放射治疗方法,这也有望推动该地区的整体市场扩张。
此外,主要区域参与者积极参与与放射治疗相关的多项进展,推动区域市场的扩张。例如,SkinCure Oncology 于 2021 年 9 月宣布,在临床试验中获得了图像引导浅表放射治疗 (IGSRT) 治疗鳞状细胞癌 (SCC) 和基底细胞癌 (BCC) 的积极数据(治愈率为 99.3%)。此外,GE Healthcare 于 2021 年 10 月在美国放射肿瘤学会 2021 年活动上展示了 15 种尖端多模态放射治疗解决方案,以加强以患者为中心的护理并推进精准医疗。由于这些最近的突破,预计该国对放射治疗的需求将增加,从而推动整个区域市场的扩张。
行业发展和未来机遇:
以下列出了全球放射治疗市场主要参与者采取的各种举措:
2023 年 5 月,GE 医疗推出了三款新产品,重点介绍放射肿瘤治疗途径,包括智能放射治疗 (IRT)、自动分割和升级版磁共振 (MR) 放射治疗套件 (AIR Open Coil Suite)。为了帮助患者过上尽可能健康的生活,这些尖端解决方案中的每一个都将在 2023 年欧洲治疗放射学和肿瘤学会大会上展出,旨在使医生能够提供最高水平的个性化护理,让他们能够访问做出明智决策所需的数据、技术和诊断。
2023 年 2 月,RefleXion Medical 获得美国 FDA 批准,可进行 SCINTIX 生物引导放射治疗,这是针对早期和晚期癌症的尖端治疗方法。
放射治疗市场报告范围
报告属性 | 细节 |
---|---|
2020 年市场规模 | 64.7 亿美元 |
2028 年市场规模 | 101.7亿美元 |
全球复合年增长率(2020 - 2028) | 5.9% |
历史数据 | 2018-2019 |
预测期 | 2021-2028 |
涵盖的领域 | 按类型
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
竞争格局和重点公司:
全球放射治疗市场的一些知名参与者包括 GE Healthcare、GE Healthcare、Elekta、ViewRay Technologies, Inc.、Accuray Incorporated、Isoray Inc.、Hitachi, Ltd.、ALCEN (PMB)、Siemens Healthineers AG 等。这些放射治疗市场专注于新产品的推出和地域扩张,以满足全球不断增长的消费者需求,并增加其专业产品组合的产品范围。它们在全球拥有广泛的业务,因此能够为众多客户提供服务,从而增加其市场份额。该报告提供了放射治疗市场趋势分析,强调了各种参数,例如技术进步、市场动态和全球主要市场参与者的竞争格局分析。
Radiotherapy Market Report Scope
Report Attribute | Details |
---|---|
Market size in | US$ 6.47 Billion |
Market Size by | US$ 10.17 Billion |
Global CAGR | 5.9% |
Historical Data | 2018-2019 |
Forecast period | 2021-2028 |
Segments Covered |
By 类型(外照射放射治疗、内照射放射治疗和全身放射治疗) |
Regions and Countries Covered |
北美(美国、加拿大、墨西哥)
|
Market leaders and key company profiles |
|
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Radiotherapy is majorly used to control the growth of a tumor while restricting the harm to nearby normal and healthy tissue. Radiotherapy uses high-energy radiation, generally x-rays, to destroy the cancer cells and treat tumors in the prostate, breast, head & neck, lung, and any other parts in the body where radiation treatment is indicated.
The growth of the market is attributed to a few key driving factors such as increasing prevalence of cancer and rising number of conferences and symposiums to boost the awareness about radiation therapy. However, increased risk of adverse effects due to radiation therapy restrains the market growth.
The radiotherapy market majorly consists of the players such as Siemens Healthineers AG, Accuray Incorporated, Sumitomo Heavy Industries, Ltd., Elekta AB, Hitachi, Ltd., Koninklijke Philips N.V., Brainlab AG, PROTOM INTERNATIONAL, Varian Medical Systems, Inc., Maastro, and Mevion Medical Systems amongst others.
The List of Companies - Radiotherapy Market
- Siemens Healthineers AG
- Accuray Incorporated
- Sumitomo Heavy Industries, Ltd.
- Elekta AB
- Hitachi, Ltd.
- Koninklijke Philips N.V.
- Brainlab AG
- PROTOM INTERNATIONAL
- Varian Medical Systems, Inc.
- Maastro
- Mevion Medical Systems
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.